ArticleAntimicrobial agents and chemotherapy2013

Persistence of resistant variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir.

Chunfu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.